Owner Glaxo Group Limited

Inventors Bertani, Barbara; Merlo, Giancarlo; Leslie, Colin Philip; Stasi, Luigi Piero; Ward, Simon Edward; Biagetti, Matteo; Vong, Antonio Kuok Keong; Bergauer, Markus; Rinaldi, Marilisa; Bromidge, Steven Mark; Tibasco, Jessica; Pizzi, Domenica Antonia; Falchi, Alessandro

Agent Davies Collison Cave

Pub. Number AU-B-2004263268

PCT Pub. Number WO2005/014552

Priority 0316915.8 18.07.03 GB

Filing date 15 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 16 December 2010

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group